Better Responses to Immunotherapy in Men – Medscape
Telegraph.co.uk |
Better Responses to Immunotherapy in Men
Medscape The meta-analysis included 20 randomized controlled trials involving more than 11,351 patients with various solid tumors treated with immunotherapy. The drugs included ipilimumab (Yervoy, Bristol-Myers Squibb), tremelimumab (MedImmune, AstraZeneca), … The Lancet Oncology: Patients' sex may impact efficacy of immunotherapy in cancer treatment Is cutting-edge cancer therapy sexist? Study finds immunotherapy works half as well for women Men Do Better than Women on Cancer Immunotherapies |
